Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | +1.57% | +14.54% | -29.78% |
05-14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
33.14M | - | - | - | - | - | |
49.18B | - | |||||
42.11B | ||||||
40.37B | ||||||
28.85B | ||||||
26.09B |